deltatrials
Completed PHASE4 NCT00358202

Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia

Phase 4 Study of Once-Daily Intramuscular Cefepime Versus Ceftriaxone for In-Home Treatment of Nursing Home-Acquired Pneumonia

Sponsor: CPL Associates

Conditions Pneumonia
Interventions cefepime ceftriaxone
Updated 5 times since 2017 Last updated: Oct 29, 2007 Started: Mar 31, 2002 Completion: Apr 30, 2006

Listed as NCT00358202, this PHASE4 trial focuses on Pneumonia and remains completed. Sponsored by CPL Associates, it has been updated 5 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Mar 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CPL Associates
  • Elan Pharmaceuticals
Data source: CPL Associates

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Buffalo, United States